“The ball is currently in the company’s court to perform postmarket studies and surveillance on purchaser influence, and also to post this details to FDA each year,” said Dr. King. “If scientific evidence implies the Web gains of those products no longer outweigh the risks within the inhabitants level—or if the company fails to carry out